Evasteo Pharmaceuticals Private Limited, a active private limited company, was established on 03 October 2017 in Perinthalmanna, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U52310KL2017PTC050582. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹6.90 M and a paid-up capital of ₹6.40 M.
It upholds a compliant status. Employing 7 professional, Its leadership includes Sreejesh (Director), Byju Kunnamkumaath Mangampully (Managing Director), Koottilingal Sajeev (Managing Director). Past directors included Sunil Uralath, Byju Kunnamkumaath Mangampully, Koottilingal Sajeev. It holds ₹9.51 M open charges and no settled loans. Its latest AGM occurred on 21 August 2024, with the balance sheet filed on 31 March 2024. It is based at Building No. 15/66Q, 1St Floor, Eva Arcade, Perinthalmanna, Kerala, 679321.
U52310KL2017PTC050582
050582
03 October 2017
₹6.90 M
₹6.40 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Evasteo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreejesh | Director | 03 Oct 2017 | Current |
| Byju Kunnamkumaath Mangampully | Managing Director | 03 Oct 2017 | Current |
| Koottilingal Sajeev | Managing Director | 03 Oct 2017 | Current |
| Ajithkumar Thottathil | Director | 03 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 01 Apr 2023 | Past |
| Pramod Abcsdd | Director | 01 Apr 2021 | Past |
| Pramod Abcsdd | Managing Director | 02 Apr 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Evasteo Pharmaceuticals Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 3.54% decrease. The company also saw a substantial improvement in profitability, with a 126.12% increase in profit. The company's net worth Soared by an impressive increase of 10.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Evasteo Pharmaceuticals had a promoter holding of 50.78% and a public holding of 49.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,506,516.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2023 | Hdfc Bank Limited | ₹1.47 M | Open |
| 30 Jun 2023 | Hdfc Bank Limited | ₹1.16 M | Open |
| 31 May 2023 | Hdfc Bank Limited | ₹1.88 M | Open |
| 13 May 2023 | Hdfc Bank Limited | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Evasteo Pharmaceuticals has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Evasteo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evasteo Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Evasteo Pharmaceuticals Private Limited last Annual general meeting of members was held on 21 Aug 2024 as per latest MCA records. was completed.
Evasteo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.47 M with Charge ID 100802713 was registered on 30 Sep 2023. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 1.16 M with Charge ID 100743967 was registered on 30 Jun 2023. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 1.88 M with Charge ID 100741267 was registered on 31 May 2023. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited of Rs. 5.00 M registered on 13 May 2023 with Charge ID 100727900 was modified on 16 May 2023. was completed.
The CIN of Evasteo Pharmaceuticals Private Limited is U52310KL2017PTC050582.
Evasteo Pharmaceuticals Private Limited is headquartered at Building No. 15/66Q, 1St Floor, Eva Arcade, Perinthalmanna, Kerala, 679321.
Evasteo Pharmaceuticals Private Limited was incorporated on 03 October 2017.
The current directors of Evasteo Pharmaceuticals Private Limited are
The primary industry of Evasteo Pharmaceuticals Private Limited is Manufacturing.
Evasteo Pharmaceuticals Private Limited is unlisted.
The authorized capital of Evasteo Pharmaceuticals Private Limited is ₹6.90 M, and the paid-up capital is ₹6.40 M.
The compliance status of Evasteo Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX